Halozyme Therapeutics
HALO
#2206
Rank
A$11.07 B
Marketcap
$89.94
Share price
-0.57%
Change (1 day)
63.73%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): A$0.71 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$0.94 Billion. In 2023 the company made an earning of A$0.54 Billion, an increase over its 2022 earnings that were of A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.71 B30.27%
2023 A$0.54 B39.94%
2022 A$0.38 B0.16%
2021 A$0.38 B92.2%
2020 A$0.20 B-278.96%
2019 -A$0.12 Billion-9.45%
2018 -A$0.13 Billion-229.51%
2017 A$96.46 M-160.48%
2016 -A$0.16 Billion216.03%
2015 -A$50.47 Million-52.86%
2014 -A$0.11 Billion-18.09%
2013 -A$0.14 Billion55.88%
2012 -A$83.86 Million169.94%
2011 -A$31.07 Million-63.44%
2010 -A$84.96 Million-7.19%
2009 -A$91.54 Million15.91%
2008 -A$78.97 Million83.89%
2007 -A$42.95 Million78.1%
2006 -A$24.12 Million16%
2005 -A$20.79 Million45.24%
2004 -A$14.32 Million682.42%
2003 -A$1.83 Million1659.12%
2002 -A$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$39.19 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.89 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.25 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.87 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.59 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
A$27.31 B 3,533.05%๐Ÿ‡บ๐Ÿ‡ธ USA